Zoladex 3.6 MG (as goserelin acetate 3.8 MG) Drug Implant
- RxCUI
- 105641
- RxNorm name
- Zoladex 3.6 MG (as goserelin acetate 3.8 MG) Drug Implant
- Display name
- Zoladex 3.6 MG (as goserelin acetate 3.8 MG) Drug Implant
- Full name
- Zoladex 3.6 MG (as goserelin acetate 3.8 MG) Drug Implant
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:51
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZOLADEX | GOSERELIN | TerSera Therapeutics LLC | 294b168b-6e5f-4db9-bf70-d599271458b3 | 2026-03-24 | Warnings, Adverse reactions | 105641 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 294b168b-6e5f-4db9-bf70-d599271458b3 | Zoladex 3.6 MG subcutaneous Drug Implant [PSN] · goserelin 3.6 MG Drug Implant [Zoladex] [SBD] · Zoladex 3.6 MG (as goserelin acetate 3.8 MG) Drug Implant [SY] · Zoladex 3.6 MG Drug Implant [SY] | 4 | 9 | These highlights do not include all the information needed to use ZOLADEX safely and effectively. See full prescribing information for ZOLADEX. ZOLADEX ® (goserelin implant) 3.6 mg Initial U.S. Approval: 1989 | 20260324 |
| a906a5bd-d2ec-4e35-8962-c0c86c637630 | Zoladex 3.6 MG subcutaneous Drug Implant [PSN] · goserelin 3.6 MG Drug Implant [Zoladex] [SBD] · Zoladex 3.6 MG (as goserelin acetate 3.8 MG) Drug Implant [SY] · Zoladex 3.6 MG Drug Implant [SY] | 4 | 6 | These highlights do not include all the information needed to use ZOLADEX safely and effectively. See full prescribing information for ZOLADEX. ZOLADEX ® (goserelin acetate implant) 3.6 mg Initial U.S. Approval: 1989 | 20210416 |